The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A DESTINY-Breast09 analysis of treatment duration and clinical outcomes by best response to trastuzumab deruxtecan (T-DXd) + pertuzumab (P).
 
Yeon Hee Park
Honoraria - AimedBio; AstraZeneca; BeOne; BMS; Daiichi-Sankyo; Eisai; Gilead Sciences; Helsinn Healthcare; Lilly; MSD; Novartis; Pfizer; Roche; Voronoi Health Analytics
Consulting or Advisory Role - AimedBio; AstraZeneca; BMS; Boryung; Daiichi-Sankyo; Eisai; Gilead Sciences; Helsinn Therapeutics; Jazz Pharmaceuticals; Lilly; Menarini; MSD; Novartis; Pfizer; Roche; Voronoi Health Analytics
Research Funding - AstraZeneca; Boryung; Daewoong Pharmaceutical; Gencurix; Gencurix (Inst); Gilead Sciences; Inocras; Inocras (Inst); Kirin Pharmaceuticals; NGeneBio (Inst); Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilad; Helsinn Therapeutics; Jazz Pharmaceuticals; Novartis; Pfizer; Roche
 
Sara Tolaney
Consulting or Advisory Role - AADi; Aktis Oncology; Ambrx; Arvinas; AstraZeneca; Avenzo Therapeutics; Bayer; BeiGene; Bicycle Therapeutics; BioNTech; Boehringer Ingelheim; Boundless Bio; Bristol-Myers Squibb; Celcuity; Circle Pharma; Corcept Therapeutics; Cullinan Oncology; Daiichi Sankyo; Denali Therapeutics; eFFECTOR Therapeutics; Eisai; Ellipses Pharma; Genentech; Immunomedics/Gilead; Jazz Pharmaceuticals; Johnson & Johnson; Launch Therapeutics; Lilly; Menarini Group; Merck; Mersana; Novartis; Olema Pharmaceuticals; Pfizer; Reveal Genomics; Samsung Bioepis; Seagen; Summit Therapeutics; Systimmune; Tempus; Zuellig Pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo; Exelixis (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Menarini/Stemlin (Inst); Merck (Inst); NanoString Technologies (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); OncoPep (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Arvinas; AstraZeneca; Gilead Sciences; Jazz Pharmaceuticals; Lilly; Pfizer; Roche
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Gilead Sciences
 
Cristina Saura Manich
Honoraria - AstraZéneca; Daiichi Sankyo/Astra Zeneca; Eisai Europe,Ltd; Exeter Pharmaceuticals; Pfizer; Phillips Health Works; Pierre Fabre; Puma Biotechnology; Roche Pharma AG; Seagen; Zymeworks
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Daiichi Sankyo; Eisai; F. Hoffmann LaRoche; Gilead Sciences; Lilly; MediTech; Menarini; Novartis; Pfizer; Pharmalex; Philips Healthcare; Pierre Fabre; Pint Pharma; Puma Biotechnology; REVEAL GENOMICS, S.L.; SeaGen; Synthon; Zymeworks
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exeter Pharmaceuticals; Lilly; Pfizer; Pierre Fabre; Puma Biotechnology; Seagen
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (BMS) (Inst); CytomX Therapeutics (Inst); Daiichi Sakyo (Inst); Debiopharm Group (Inst); Genentech (Inst); GlaxoSmithKline (Inst); InnoUp (Inst); Janssen-Cilag SA (Inst); Lilly (Inst); Macrogenics (Inst); Menarini (Inst); Merck Health KGAA, Merck Sharp & Dohme (Inst); Merus (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Puma Biotechnology (Inst); Roche (Inst); Roche (Inst); Sanofi/Aventis (Inst); Seagen (Inst); SERVIER (Inst); Spanish Association Against Cancer Scientific Foundation and Cancer Research UK (Inst); Taiho Pharma USA Inc, (Inst)
Expert Testimony - AX`s consulting SARL; Boehringer Ingelheim; Bristol-Myers Squibb/Sanofi; Genentech; InnoUp; Merck Sharp and Dohme Spain; Novartis; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Eisai Europe; Gilead Sciences; Lilly; Novartis; Pfizer; Pierre Fabre; Pierre Fabre; Puma Biotechnology; Roche; Seagen
(OPTIONAL) Uncompensated Relationships - Fundación SOLTI
 
Zefei Jiang
No Relationships to Disclose
 
Mothaffar Rimawi
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Novartis; Pfizer; Stemline Therapeutics; Tempus
Research Funding - Greenwich LifeSciences (Inst)
 
Romualdo Barroso-Sousa
Consulting or Advisory Role - AstraZeneca; AstraZeneca/Daiichi Sankyo; AstraZeneca/Merck; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Libbs; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - AstraZeneca/Daiichi Sankyo
Travel, Accommodations, Expenses - AstraZeneca/Daiichi Sankyo; AstraZeneca/Daiichi Sankyo; MSD; Novartis; Roche
Other Relationship - RD EDUCACAO MEDICA
 
Andreas Schneeweiss
Honoraria - Amgen; AstraZeneca; Aurikamed; ClinSol; coma UroGyn; Connectmedica; Daiichi Sankyo; Gilead Sciences; GlaxoSmithKline; I-MED; if-kongress; iOMEDICO; Lilly; MCI Deutschland; MSD; Novartis; Onkowissen; Pfizer; Promedicis; Roche; Seagen; Streamedup!
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; Gilead Sciences; Pfizer; Roche
 
Masakazu Toi
Honoraria - AstraZeneca; Chugai Pharma; Daiichi Sankyo; Devicor Medical Products; Eisai; Exact Sciences; Kyowa Kirin; Lilly; MSD; Nippon Kayaku; Pfizer; Taiho Pharmaceutical; TAKEDA; Yakult Pharmaceutical
Consulting or Advisory Role - Bertis; Daiichi Sankyo; Lilly
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Lilly; Pfizer
Patents, Royalties, Other Intellectual Property - JP 2017-143763 WO2017/131162A1 (Inst); PCT/JP2016/004374 (Inst)
Other Relationship - Asian Journal of Surgery; Asian Journal of Surgery; Breast Cancer research and Treatment; British Journal of Cancer; Cancer Science; Japanese Breast Cancer Society; Kyoto Breast Cancer Research Network; Organization for Oncology and Translational Research; Scientific Reports
 
Qingyuan Zhang
No Relationships to Disclose
 
Seock-Ah Im
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pfizer; Roche/Genentech; SK Biopharmaceutical
Research Funding - AstraZeneca (Inst); Boryung Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
(OPTIONAL) Uncompensated Relationships - Roche
 
Umut Demirci
Honoraria - Abdi Ibrahim; AstraZeneca; AstraZeneca; BMS Turkey; CTGEN; Daiichi Sankyo/Astra Zeneca; Gen; Gilead Sciences; GlaxoSmithKline; Lilly; Menarini; Merck Serono; MSD; Novartis; Roche; Sandoz
Consulting or Advisory Role - Gilead Sciences; Menarini; MSD; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Gen; Pfizer
 
Cynthia Villarreal-Garza
Honoraria - Lilly; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Amplity Health; Lilly; MSD Oncology; Novartis
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Pfizer
 
Valentina Guarneri
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Exact Sciences; Gilead Sciences; Lilly; Menarini Group; MSD; Novartis; Olema Oncology; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - Abbvie; AstraZeneca; Daiichi Sankyo; Gilead Sciences; Lilly; Menarini Steamline; Novartis; Pfizer; Roche
Research Funding - AstraZeneca (Inst); BMS (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Nerviano Medical Sciences (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Synthon (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead/Forty Seven; Menarini Group; Roche
 
Shoubhik Mondal
Employment - AstraZeneca
 
Doudou Huang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Jagdish Shetty
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Angela Zeng
Employment - AstraZeneca
 
Sibylle Loibl
Employment - GBG Forschungs; Goethe Universität / Universitätsklinikum Frankurt/Main
Consulting or Advisory Role - Abbvie (Inst); American Institute of Continuing Medical Education (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); BeiGene (Inst); Bicycle Therapeutics (Inst); BMS (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Corcept Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai Europe (Inst); GlaxoSmithKline (Inst); Jazz Pharmaceuticals (Inst); Jiangsu Hengrui Pharmaceuticals (Inst); Lilly (Inst); Menarini Group (Inst); MICE ideas (Inst); MSD Oncology (Inst); Novartis (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst)
Speakers' Bureau - Agendia (Inst); AstraZeneca (Inst); Bayer (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Medscape (Inst); Menarini Group (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Stemline Therapeutics (Inst); Streamedup! (Inst)
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); Greenwich LifeSciences (Inst); Menarini Group (Inst); MolecularHealth (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - Digital Ki67 Evaluator, VM Scope GmbH (Inst); Patent Issued EP15702464.7 (Inst); Patent Pending EP14153692.0 (Inst); Patent Pending EP19808852.8 (Inst); Patent Pending EP21152186.9 (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Gilead Sciences (Inst); MSD (Inst); Roche (Inst)